Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer

NCT03053544 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Rectal Neoplasm Carcinoma in Situ Adenocarcinoma

Interventions

DRUG: Metformin

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]
[object Object]